文献速递肿瘤 PET/CT核素与放射性配体治疗

读者培训用于18F-氟司洛文PET/CT对生化复发前列腺癌再分期

Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT.
PubMed 文献 · J Nucl Med · 2017-04-06

本研究为盲法图像评估,110例生化复发前列腺癌患者的121幅18F-氟司洛文PET/CT图像经标准化判读方法培训后由3名初学者判读。病灶水平总阳性预测值为70.5%,前列腺区敏感度高(91.4%)但特异度中等(48.7%),读者间一致性为94.7%、74.4%、70.3%(病灶、前列腺、前列腺外),对应Fleiss κ值0.54、0.50、0.57。结论认为经特定培训后初学者可达到可接受的诊断效能和可重复性。

要点

  • 病灶水平总阳性预测值为70.5%,读者间一致性在病灶水平为94.7%(κ=0.54)。
  • 前列腺区敏感度为91.4%、特异度为48.7%,特异度中等。
  • 前列腺外区域读者间一致性为70.3%(κ=0.57),前列腺区为74.4%(κ=0.50)。

核心结论

  • 经标准化判读方法特定培训后,初学者对18F-氟司洛文PET/CT再分期生化复发前列腺癌可达到可接受的诊断效能和可重复性。

研究设计与样本

  • 盲法图像评估研究,收集110例受试者的121幅18F-氟司洛文PET/CT图像及标准真相数据(组织病理学或临床随访)。
  • 图像采用单时间点静态采集,注射约370 MBq 18F-氟司洛文后5分钟开始采集,来自Emory大学。
  • 3名读者经标准化判读方法培训后以盲法评估图像,分析在病灶、区域(前列腺包括床和精囊,或前列腺外包括所有淋巴结、骨或软组织转移)和受试者水平进行。
  • 主要目标为建立个体读者诊断效能和总体判读(2/3读者一致)并与标准真相数据比较,以及评估读者间可重复性;次要目标包括与专家读者比较和评估读者内可重复性。

主要发现

  • 病灶水平总阳性预测值为70.5%。
  • 读者1和读者2的敏感度最高(分别为68.5%和63.9%),读者3的特异度最高(83.6%)。
  • 前列腺水平总体敏感度高(91.4%),但特异度中等(48.7%)。
  • 读者间一致性在病灶、前列腺和前列腺外水平分别为94.7%、74.4%和70.3%,对应Fleiss κ值分别为0.54、0.50和0.57。
  • 读者内一致性:病灶水平读者1、2、3分别为97.8%、96.9%、99.1%;前列腺区分别为100%、100%、91.7%;前列腺外区分别为83.3%、75.0%、83.3%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-Fluciclovine is a novel PET/CT tracer. This blinded image evaluation (BIE) sought to demonstrate that, after limited training, readers naïve to 18F-fluciclovine could interpret 18F-fluciclovine images from subjects with biochemically recurrent prostate cancer with acceptable diagnostic performance and reproducibility. The primary objectives were to establish individual readers' diagnostic performance and the overall interpretation (2/3 reader concordance) compared with standard-of-truth data (histopathology or clinical follow-up) and to evaluate interreader reproducibility. Secondary objectives included comparison to the expert reader and assessment of intrareader reproducibility. Methods:18F-Fluciclovine PET/CT images (n = 121) and corresponding standard-of-truth data were collected from 110 subjects at Emory University using a single-time-point static acquisition starting 5 min after injection of approximately 370 MBq of 18F-fluciclovine. Three readers were trained using standardized interpretation methodology and subsequently evaluated the images in a blinded manner. Analyses were conducted at the lesion, region (prostate, including bed and seminal vesicle, or extraprostatic, including all lymph nodes, bone, or soft-tissue metastasis), and subject level. Results: Lesion-level overall positive predictive value was 70.5%. The readers' positive predictive value and negative predictive value were broadly consistent with each other and with the onsite read. Sensitivity was highest for readers 1 and 2 (68.5% and 63.9%, respectively) whereas specificity was highest for reader 3 (83.6%). Overall, prostate-level sensitivity was high (91.4%), but specificity was moderate (48.7%). Interreader agreement was 94.7%, 74.4%, and 70.3% for the lesion, prostate, and extraprostatic levels, respectively, with associated Fleiss' κ-values of 0.54, 0.50, and 0.57. Intrareader agreement was 97.8%, 96.9%, and 99.1% at the lesion level; 100%, 100%, and 91.7% in the prostate region; and 83.3%, 75.0%, and 83.3% in the extraprostatic region for readers 1, 2, and 3, respectively. Concordance between the BIE and the onsite reader exceeded 75% for each reader at the lesion, region, and subject levels. Conclusion: Specific training in the use of standardized interpretation methodology for assessment of 18F-fluciclovine PET/CT images enables naïve readers to achieve acceptable diagnostic performance and reproducibility when staging recurrent prostate cancer.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Miller MP, Kostakoglu L, Pryma D, et al. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT. J Nucl Med. 2017. PMID: 28385791. doi:10.2967/jnumed.116.188375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。